Teleflex Medical: FDA filings under this applicant name
FDA lists 43 510(k) clearances under 2 spellings of the applicant name “Teleflex Medical” (first 2003, latest 2026), across 22 product codes in 6 review panels. Median 510(k) review time under this name: 87 days. Since 2017 the median was 106 days, against 125 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
Caduvo groups this applicant name under Teleflex, based on public ownership records.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 1 | 352 |
| 2013 | 3 | 93 |
| 2014 | 0 | — |
| 2015 | 0 | — |
| 2016 | 2 | 166 |
| 2017 | 1 | 92 |
| 2018 | 5 | 99 |
| 2019 | 2 | 128 |
| 2020 | 2 | 146 |
| 2021 | 1 | 203 |
| 2022 | 1 | 31 |
| 2023 | 3 | 65 |
| 2024 | 3 | 113 |
| 2025 | 3 | 120 |
| 2026 | 1 | 146 |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Teleflex Medical took a median 106 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 125 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| GAT | Suture, Nonabsorbable, Synthetic, Polyethylene | 8 | 8 |
| FZP | Clip, Implantable | 7 | 7 |
| FMI | Needle, Hypodermic, Single Lumen | 3 | 3 |
| GAM | Suture, Absorbable, Synthetic, Polyglycolic Acid | 3 | 3 |
| BSP | Needle, Conduction, Anesthetic (W/Wo Introducer) | 2 | 2 |
| BTR | Tube, Tracheal (W/Wo Connector) | 2 | 2 |
| BTT | Humidifier, Respiratory Gas, (Direct Patient Interface) | 2 | 2 |
| EZC | Catheter, Coude | 2 | 2 |
| BSO | Catheter, Conduction, Anesthetic | 1 | 1 |
| BTO | Tube, Tracheostomy (W/Wo Connector) | 1 | 1 |
Plus 12 more product codes.
Review panels
- General and Plastic Surgery (21)
- Anesthesiology (11)
- Gastroenterology and Urology (4)
- General Hospital (4)
- Cardiovascular (2)
- Orthopedic (1)
Most recent Teleflex Medical 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K261418 | Liquick X-treme, Liquick X-treme Plus | EZD | 2026-09-23 | 146 |
| K251054 | Hem-o-lok PurplePlus Large Polymer Ligating Clips | FZP | 2025-07-03 | 90 |
| K242495 | LMA Fastrach ETT SU | BTR | 2025-04-29 | 250 |
| K243553 | QuikClot Control+ Hemostatic Device | POD | 2025-03-18 | 120 |
| K241784 | Arrow® Nitinol Wire | DQX | 2024-09-18 | 90 |
| K233713 | Pilling Tracheostomy Tubes | BTO | 2024-03-22 | 123 |
| K232970 | Hem-o-lok® Ligating Clips | FZP | 2024-01-12 | 113 |
| K230603 | Arrow Non-Stimulating SnapLock Adapter (K-05520-005C); Arrow Non-Stimulating Next Gen SnapLock Adapter (Luer Connection) (CA-000010-19); Arrow Non-Stimulating Next Gen SnapLock Adapter (Neuraxial Connection) (CA-000014-19); Arrow Stimulating SnapLock Adapter (with cable) (TZ-02060-001); Arrow Stimulating SnapLock Adapter (with tab) (TZ-05000-002) | BSO | 2023-08-30 | 180 |
| K231924 | EZ-IO Intraosseous Vascular Access System | FMI | 2023-07-25 | 25 |
| K230480 | Weck Auto Endo5 5mm Automatic Endoscopic 35cm Applier (AE05ML) | FZP | 2023-04-28 | 65 |
33 earlier clearances. See the full list in Caduvo.
Recalls
303 product recalls in 120 recall events; 9 initiated in the last five years. Most recent: 2022-04-11.
2 product recalls in 2 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 1 initiated in the last five years. Most often: TELEFLEX LLC (1), Telefelx Medical (1).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Parent company SEC filings
TELEFLEX INC (TFX): EDGAR filings, CIK 96943. Caduvo groups Teleflex Medical under Teleflex; the parent's SEC registrant is entered by hand for the group, not matched by name.
FDA spellings included
FDA records this applicant under 2 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:
- Teleflex Medical (40)
- Teleflex Medical Incorporated (3)
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Teleflex, Inc. (11 510(k)s)
- Teleflex Medical, LLC (3 510(k)s)
- Teleflex Medical Sdn. Bhd. (3 510(k)s)
- Teleflex Medical Group (1 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Teleflex Medical?
FDA lists 43 510(k) clearances under 2 spellings of the applicant name “Teleflex Medical” (first 2003, latest 2026), across 22 product codes in 6 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Teleflex Medical?
The median time from FDA receipt to decision across 510(k)s cleared under the name Teleflex Medical is 87 days. Since 2017: 106 days, versus 125 days for all cleared 510(k)s in the same product codes.
Which FDA product codes appear under Teleflex Medical?
The most frequent FDA product codes under this applicant name are GAT (Suture, Nonabsorbable, Synthetic, Polyethylene, 8); FZP (Clip, Implantable, 7); FMI (Needle, Hypodermic, Single Lumen, 3).
Next steps
- See all 43 Teleflex Medical clearances with predicates and recalls
- Run predicate analysis for product code GAT, Teleflex Medical's most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.